Williams J L, Malik K U
Department of Pharmacology, College of Medicine, University of Tennessee, Memphis 38163.
Circ Res. 1990 Nov;67(5):1247-56. doi: 10.1161/01.res.67.5.1247.
Infusion of forskolin, an adenylate cyclase activator, in concentrations (2 microM) that do not alter basal prostaglandin (PG) synthesis inhibit synthesis of PG elicited by isoproterenol in rabbit heart. This inhibitory action of forskolin appears to be dependent on cyclic AMP (cAMP). Bolus injection of forskolin (75 nmol), however, was found to stimulate PG synthesis in rabbit heart. The purpose of this study was to elucidate the mechanism of the stimulatory action of forskolin on PG synthesis (prostaglandin I2 measured as 6-ketoprostaglandin F1 alpha [6-keto-PGF1 alpha]) in isolated perfused rabbit heart. Forskolin enhanced PG production in a dose-dependent manner. 1,9-Dideoxyforskolin, a forskolin analogue devoid of adenylate cyclase-stimulating activity, also enhanced PG synthesis. The cAMP analogue chlorophenylthio-cAMP failed to stimulate output of 6-keto-PGF1 alpha, although this agent produced dose-related changes in mechanical function in rabbit heart. Furthermore, the adenylate cyclase inhibitor (-)-N6-(R-phenylisopropyl)adenosine potentiated, whereas the phosphodiesterase inhibitor cilostamide attenuated, forskolin-stimulated PG production. (-)-N6-(R-Phenylisopropyl)adenosine and cilostamide had no effect on the mechanical actions of chlorophenylthio-cAMP, suggesting selectivity of these agents for adenylate cyclase and phosphodiesterase, respectively. 6-Keto-PGF1 alpha output elicited by forskolin was abolished by reduction of calcium in the perfusion fluid as well as by the calcium channel blocker diltiazem. The intracellular calcium antagonists TMB-8 and ryanodine also abolished forskolin-stimulated PG synthesis in rabbit heart. PG synthesis stimulated by 1,9-dideoxyforskolin was also prevented by reduced extracellular calcium, diltiazem, and ryanodine. The calmodulin antagonists trifluoperazine, W-7, and calmidazolium failed to significantly alter PG production in response to forskolin. These results indicate that forskolin-stimulated PG synthesis in rabbit heart is independent of cAMP and requires calcium from both extracellular and intracellular sources.
向兔心脏灌注腺苷酸环化酶激活剂福斯高林,其浓度(2微摩尔)不改变基础前列腺素(PG)合成,但可抑制异丙肾上腺素引发的PG合成。福斯高林的这种抑制作用似乎依赖于环磷酸腺苷(cAMP)。然而,静脉注射福斯高林(75纳摩尔)可刺激兔心脏PG合成。本研究的目的是阐明福斯高林对离体灌注兔心脏PG合成(前列腺素I2以6-酮前列腺素F1α[6-酮-PGF1α]衡量)的刺激作用机制。福斯高林以剂量依赖的方式增强PG生成。1,9-二脱氧福斯高林,一种缺乏腺苷酸环化酶刺激活性的福斯高林类似物,也增强PG合成。cAMP类似物氯苯硫基-cAMP未能刺激6-酮-PGF1α的生成,尽管该药物在兔心脏中产生了与剂量相关的机械功能变化。此外,腺苷酸环化酶抑制剂(-)-N6-(R-苯异丙基)腺苷增强,而磷酸二酯酶抑制剂西洛他唑减弱福斯高林刺激的PG生成。(-)-N6-(R-苯异丙基)腺苷和西洛他唑对氯苯硫基-cAMP的机械作用无影响,表明这些药物分别对腺苷酸环化酶和磷酸二酯酶具有选择性。灌注液中钙的减少以及钙通道阻滞剂地尔硫卓可消除福斯高林引发的6-酮-PGF1α生成。细胞内钙拮抗剂TMB-8和ryanodine也可消除福斯高林刺激的兔心脏PG合成。细胞外钙减少、地尔硫卓和ryanodine也可阻止1,9-二脱氧福斯高林刺激的PG合成。钙调蛋白拮抗剂三氟拉嗪、W-7和氯米达唑未能显著改变福斯高林刺激的PG生成。这些结果表明,福斯高林刺激的兔心脏PG合成不依赖于cAMP,且需要细胞外和细胞内来源的钙。